BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12557713)

  • 1. [Weekly administration of paclitaxel and pirarubicine for recurrent breast cancer].
    Shimizu T; Iwasa T; Koike S; Nakamura T; Kanai T; Komatsu D
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):105-9. PubMed ID: 12557713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy and safety of weekly taxol (TXL) for advanced recurrent breast cancer evaluated in a multi-center cooperative clinical trial].
    Nishi T; Yamanaka E; Yamasaki M; Tanaka H; Takeda C; Ikeda N; Hoashi T; Higaki J; Matsunami T; Nakano K; Kogire M; Furukawa J; Inui N; Yamauchi E; Takagaki K; Ogino N; Nomura T; Yamada S; Fujimoto M; Uenishi M; Yayoi E;
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):897-901. PubMed ID: 15222108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A phase II study of weekly paclitaxel for advanced or recurrent breast cancer].
    Wada Y; Otoshi M; Jitsuko A; Nishikawa H; Takahara S; Tsubono M; Imai S
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1041-5. PubMed ID: 17637539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A phase I study of combination chemotherapy using TS-1 and pirarubicin (THP) for advanced gastric cancer].
    Yamamura Y; Kodera Y; Tanemura H; Oshita H; Miyashita K; Fujimura T;
    Gan To Kagaku Ryoho; 2004 Mar; 31(3):361-5. PubMed ID: 15045941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I evaluation of continuous 5-fluorouracil infusion followed by weekly paclitaxel in patients with advanced or recurrent gastric cancer.
    Kondo K; Kobayashi M; Kojima H; Hirabayashi N; Kataoka M; Araki K; Matsui T; Takiyama W; Miyashita Y; Nakazato H; Nakao A; Sakamoto J
    Jpn J Clin Oncol; 2005 Jun; 35(6):332-7. PubMed ID: 15961435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Weekly administration of paclitaxel for advanced or metastatic breast cancer--short-course premedications for outpatients].
    Kimura M; Koida T; Yanagita Y
    Gan To Kagaku Ryoho; 2000 Oct; 27(11):1703-8. PubMed ID: 11057321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined chemotherapy with weekly paclitaxel and carboplatin for recurrent and refractory epithelial ovarian cancer--phase I study].
    Misawa A; Yasuda M
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1445-52. PubMed ID: 17033235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of S-1 and biweekly docetaxel combination chemotherapy for advanced and recurrent gastric cancer.
    Takahashi I; Emi Y; Kakeji Y; Tokunaga E; Ushiro S; Oki E; Watanabe M; Baba H; Maehara Y
    Oncol Rep; 2006 Apr; 15(4):849-54. PubMed ID: 16525670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Weekly paclitaxel therapy for metastatic breast cancer].
    Kokufu I; Taniguchi H; Kimura F; Fukuda K; Yamamoto M; Yano T; Yamada K
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):221-6. PubMed ID: 11865627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of effects from neoadjuvant chemotherapy with epirubicin plus paclitaxel in cases of locally advanced breast cancer--comparative study of treatment with 2 and 4 cycles].
    Tong F; Yang D; Zhou B; Cao Y; Liu P; Liu H; Wang S; Qiao X; Zhang J
    Gan To Kagaku Ryoho; 2004 Feb; 31(2):205-8. PubMed ID: 14997752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Weekly administration of low-dose paclitaxel for advanced or metastatic breast cancer].
    Uno Y; Hirano M; Murakami N; Kikuchi T; Nozawa H; Okuda T; Oya J; Kikkawa H
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):227-32. PubMed ID: 11865628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Weekly paclitaxel therapy for locoregional lymph node recurrence of estrogen-receptor-negative breast cancer].
    Nishimura H; Hamanaka K; Sakai H; Ohno Y; Miyagawa Y; Seki H; Munakata Y
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):627-30. PubMed ID: 15114714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Paclitaxel and carboplatin with or without pirarubicin (THP-ADR) as first line chemotherapy in elderly patients].
    Nagao S; Okimoto N; Hongo A; Mizutani Y; Kodama J; Yoshinouchi M; Hiramatsu Y; Kudo T
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):243-9. PubMed ID: 12610873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Weekly paclitaxel infusion in patients with recurrent ovarian cancer--a pilot study].
    Kawagoe H; Kawata T; Nishio S; Shimomura T; Fujiyoshi K; Ishimatsu J; Tsunawaki A
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):151-4. PubMed ID: 12557722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two cases of effective weekly paclitaxel administration for metastatic breast cancer].
    Kokufu I; Taniguchi H; Kim Y; Fukuda K; Yamamoto M; Yano T; Yamada K; Kitano H
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1905-8. PubMed ID: 11729485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential administration of epirubicin and paclitaxel for advanced breast cancer. A phase I randomised trial.
    Focan C; Graas MP; Beauduin M; Canon JL; Salmon JP; Jerusalem G; Focan-Henrard D; Lobelle JP; Schallier D
    Anticancer Res; 2005; 25(2B):1211-7. PubMed ID: 15865068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined chemoendocrine therapy using adriamycin, cyclophosphamide and high dose toremifene in patients with recurrent breast cancer].
    Wada N; Kobayashi H; Oka S; Ando J; Tamura H
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):1935-42. PubMed ID: 12465393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phase II study of THP (2''R)-4'-0-tetrahydropyranyladriamycin) in breast cancer].
    Abe O; Enomoto K; Tominaga T; Kasai Y; Soejima S; Kasai M; Izuo M; Yoshida M; Kubo K; Terasawa T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):578-85. PubMed ID: 3954379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A study on the efficacy of combination chemoendocrine therapy consisting of cyclophosphamide, adriamycin, UFT, and tamoxifen for advanced or recurrent breast cancer].
    Yamaguchi S; Fukuda M; Ota T; Nakayama Y; Ogata H; Shimizu K; Nishikawa T; Adachi Y; Fukuma E
    Gan To Kagaku Ryoho; 1999 Jul; 26(8):1145-52. PubMed ID: 10431580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adjuvant doxorubicin and cyclophosphamide followed by weekly paclitaxel for Japanese women with node-positive breast cancer: a multi-institutional feasibility study in a variety of practice settings in Kyushu].
    Anan K; Mitsuyama S; Taniguchi H; Yamamoto Y; Fujiyoshi K; Tateishi T; Tamura K
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1417-22. PubMed ID: 17033230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.